HEALTHSTAT NEWS
Opinion: $2 million gene therapy cures require a financing model
Gene therapies can cure diseases like sickle cell with a single treatment but cost over $2 million per patient. The article argues these high costs are justified by long-term savings from avoiding hospitalizations, complications, and lost productivity.
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
- Cancer treatment already costs hundreds of thousands of dollars — and it’s about to get even worse
- Personalized CRISPR therapies could soon reach thousands — here’s how
- Revealed: The healthcare fat cats making a fortune from the ballooning ADHD 'crisis'... and how the diagnosis industry has tripled benefits spending to £577 million in just four years
- Economic reform can save antibiotic innovation
- Daily briefing: CAR-T-cell therapy keeps a trio of autoimmune diseases at bay